Editorial Policy

Policy revised: October 16, 2026. Provider evidence has its own dates.

This page explains how we research GLP-1 programs, what our scores mean and how commissions affect what you see.

In short: we score each program from its published prices, care and terms with a fixed rubric, and a commission never changes a score or the order of a price list.

We cover programs that pay us (affiliate partners), programs we keep records on without a partnership, and selected independent reviews.

A review does not mean we have an active affiliate offer with that program.

How do commissions affect what you see?

A commission never changes a provider's score. We give partners low scores when the evidence calls for it, and we disclose every commercial relationship so you can judge our recommendations.

Our directory and program finder let you browse by name, medication, form and price. They are not a ranking of care quality, and they do not cover every program on the market.

Each score keeps its stated limitations, and an incomplete record does not make one provider better or worse than another. A partnership never changes a score or the order of a price list.

Our "Top Pick" and the three programs we feature for an easy start are different: we choose them only from affiliate partners that pass our pick rule, and we may favor partners that pay us more.

They are labeled as featured, and we earn a commission on them.

How do we score GLP-1 telehealth programs?

We score every program out of 10 on one published rubric, the same for partners and non-partners. A score grades what a program publishes about its prices, care and terms. It is not a patient rating, a clinical outcome or a safety guarantee, and a higher score does not mean a treatment will work better for you.

We grade five areas, each with a fixed weight that payment never changes:

  • Cost & Pricing (25%): the cheapest all-in monthly price, consultation and shipping fees, a price that holds as your dose rises, and multi-month discounts
  • Published Clinical Support (25%): a named medical director, licensed and board-certified prescribers, lab testing, video visits, a named compounding pharmacy and LegitScript or NABP certification
  • Medication Options (20%): compounded and brand-name options, oral GLP-1s, brand pricing, insurance and prior-authorization help
  • User Experience (15%): time to your first medication, prices before sign-up, dose management, a published reply time, emergency guidance, cancellation and refunds
  • Transparency (15%): the legal company behind the program, a verifiable medical director, the pharmacy, the full monthly cost and certifications

What does a 10 mean?

A 10 means a program matches the 4th-best program we checked in that area. A 10 is not a perfect record: even top programs leave items unpublished. We set that bar from the evidence we held on our 37 published programs in October 2026, record the evidence version it came from (evidence commit 0eb3523b), and keep it fixed until v2027.1, so new evidence moves a program's score but never moves the bar. A program that beats the bar in one area cannot use that to cover a weak area elsewhere.

How do we treat what a program does not offer?

We score each offer once and never mark a program down for a detail of something it does not sell. A compounded-only program is not graded on brand-name pricing or insurance, a program that takes no insurance is not graded on prior-authorization help, and a brand-only program is not graded on naming a compounding pharmacy. Information a program does not publish earns no credit and stays in the score: unpublished is not the same as absent, and it does not prove poor care.

Eight nice-to-know items count half, because they never change what you pay, how safe your care is or whether you get your medication: a separate low-dose tier, a short sign-up, an app, built-in logging, a named leadership team, a founding year, listed prescribers and links to outside reviews.

What do the score words mean?

9.0 to 10, Excellent
Matches the 4th-best program in nearly every area.
8.0 to 8.9, Very good
Strong in most areas, with a few gaps.
7.0 to 7.9, Good
Solid in most areas, with some clear gaps.
6.0 to 6.9, Fair
Covers the basics, with gaps worth checking.
5.0 to 5.9, Mixed
Real strengths alongside gaps in several areas.
Below 5.0, Limited
Offers or publishes much less than the market.

A program needs at least half the clinical standard of the best programs to be called Good or better, whatever its price. Below that line the word stays at Fair and the number does not change.

How do we choose what a program does well?

Each review opens with up to three things the program does well and up to three things to watch out for. We list a strength only when we read it on the program's own site in the last 90 days and recorded the page and the date, and never when an active alert covers the same subject. Money and care come first. A strength almost every program shares only fills a short list. Each watch-out stays true whether the item is missing or simply unpublished, and gaps most programs share stay off the list.

When does a program show an alert instead of a score word?

Four findings hurt readers enough that we show them as a dated alert, in the place of the score word and as visible as the score. An alert never changes the number. While an alert is active, the program cannot be our Top Pick, hold a featured spot or appear on a best list, partner or not. We make one exception, as a commercial choice: Embody keeps its featured spot while its delivery-complaints alert is active, and every Embody card and its review show that alert. An alerted program's review stays up, with the alert in the score line and its sources before any link to the program.

  • FDA warning: an open FDA warning letter, with its number and fda.gov link. It clears when FDA posts a close-out letter.
  • Delivery complaints: at least 4 of the 10 newest BBB complaints and at least 4 of the 20 newest one-star Trustpilot reviews describe paid medication that did not arrive. We re-check every 14 days, and it clears after two re-checks at least 14 days apart each find fewer than 3 in both.
  • BBB alert: BBB itself shows a Pattern of Complaints alert on the business profile. It clears when BBB removes it.
  • Stock-photo testimonial: an ad or page presents a stock photo as a customer's own result. It clears when a dated re-check of the site and active ads finds none.

Trustpilot ratings, BBB letter grades and closed FDA letters are shown as information with their dates. They never move a score.

Which programs can be a pick?

A program can be our Top Pick, hold a featured or commercial spot, or appear on a best list only when it has no active alert, scores 6.0 or more, and we checked its evidence within the last 90 days. The same rule applies to every program, with the one exception described above for Embody. Among programs that pass it, featured spots may follow affiliate economics, and we label them as featured. Every score shows the date we checked it.

How do we research a program?

  • We review each provider's website, pricing pages, and sign-up flow
  • We reference published clinical trial data for medication efficacy claims (e.g., STEP, SURMOUNT, OASIS trials published in NEJM)
  • We use FDA prescribing information as the source for side effect data
  • We reference CMS and state Medicaid program announcements for insurance coverage information
  • Price checks carry individual dates; a page revision does not reverify every provider fact

Which evidence supports each kind of answer?

  • Prices and service terms: provider product pages, published policies and dated plan records support what a seller advertises. They do not establish the bill for a particular patient, prescription approval or treatment outcomes. Keep the product, administration route, required fees, first payment, renewal and commitment with the price.
  • Medication and regulatory facts: the relevant FDA label, notice or other official record supports the claim within its stated scope. A provider's marketing copy or affiliate approval does not independently establish medication approval, compounding compliance or safety.
  • Clinical results: use the cited study's formulation, dose, population, outcome and follow-up period. A result for one branded product or administration route does not automatically apply to another formulation or compounded preparation. Separate-study averages are not a head-to-head treatment ranking.
  • Coverage: CMS, state programs, insurers and plan documents support their own eligibility and coverage conditions. Prior-authorization assistance, provider insurance acceptance and medication coverage are separate facts; none guarantees a reader's approval.
  • Customer experiences: reviews and complaint records are attributed accounts, not controlled clinical evidence. A complaint does not prove every customer has the same experience, and missing information is not proof a service is absent.

When quoting our original comparison or dataset, link to its exact public page and preserve the verification date, billing basis and material unknowns.

Follow its original sources for claims they establish. Our publication facts identify the publisher and coverage boundaries.

How do we use AI assistance?

We use AI tools to assist with research, drafting, organizing comparisons and technical checks. An AI answer is not primary evidence.

Named authorship identifies editorial responsibility, not a guarantee of personal approval or clinical review of every page.

A clinician's review must be explicitly identified before it can be claimed.

How do we handle medical claims?

  • We do not make our own claims about how well a drug works; we cite published trial results and FDA-approved labeling
  • When discussing medication benefits, we include relevant risk information (fair balance)
  • We cite our sources and link to primary sources when possible
  • We do not promote off-label drug use
  • We clearly distinguish between FDA-approved medications and compounded alternatives

How do you report a mistake?

If you notice inaccurate information, please contact thecompoundgroupco@gmail.com with the page URL, disputed fact and supporting source.

We investigate corrections and preserve material qualifications; we do not promise a resolution before the evidence is checked.

How current is this information?

GLP-1 prices and rules change quickly.

A page's publication and revision dates describe the page; each price check and source check carries its own date, and we leave older or missing dates visible.

A new layout or policy wording is not a new price check.

Confirm time-sensitive terms with the provider and the original source before you act.

Related: how we make money and who we are.